Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus
Elisa Y. Rhew(Northwestern University), Rosalind Ramsey‐Goldman(Northwestern University), Kim Sutton-Tyrrell(University of Tennessee Health Science Center), George T. Kondos(University of Illinois Chicago), Amy Kao(Allegheny Health Network), David D. McPherson(The University of Texas Health Science Center at Houston), Emma Barinas‐Mitchell(University of Pittsburgh), Natalya Danchenko(University of Pittsburgh), William H. Pearce(National Institutes of Health), Daniel Edmundowicz(Temple University Hospital), Susan Manzi(Allegheny Health Network), Alan R. Dyer(Northwestern University)
Cited by 37
Related Papers
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
|Circulation|2005|1.2k
Inflammatory Markers and Onset of Cardiovascular Events
|Circulation|2003|976
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
|The Lancet Rheumatology|2019|478
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
|Nature Genetics|2011|284
Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|274